Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00521833
Other study ID # 8380
Secondary ID
Status Completed
Phase N/A
First received August 27, 2007
Last updated September 4, 2007
Start date June 2005
Est. completion date August 2006

Study information

Verified date August 2007
Source hahid Beheshti University of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority Iran: Ethics Committee
Study type Interventional

Clinical Trial Summary

To compare the short-term astigmatic outcomes of phacoemulsification cataract surgery and intraocular lens implantation using temporal versus nasal clear corneal incisions.


Description:

In a clinical trial, consecutive eyes with senile cataract underwent phacoemulsification with implantation of a 6.0 mm foldable hydrophobic acrylic intraocular lens through a 3.2 mm horizontal clear cornea incision at 180 degrees (temporal incision in right eyes, nasal incision in left eyes). Keratometric astigmatism was measured preoperatively and one and four weeks and 6 months after surgery. Surgically induced astigmatism (SIA) was calculated by the vector analysis method using the Holladay-Cravy-Koch formula. Patients with history of diabetes mellitus, connective tissue disorders, steroid use, previous ocular surgery, with the rule astigmatism >1D, pseudoexfoliation and any corneal pathology were excluded.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date August 2006
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- All the patients with senile cataract

Exclusion Criteria:

- Previously operated eyes

- Presence of corneal pathology

- Pseudo exfoliation

- With-the-rule (WTR) astigmatism >1 D

- Presence of diabetes mellitus

- History of connective tissue disease

- Consumption of systemic steroids

Study Design

Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
phacoemulsification and intraocular lens implantation
clear cornea phacoemulsification and intraocular lens implantation using temporal or nasal incisions respectively

Locations

Country Name City State
Iran, Islamic Republic of Ophthalmic research center Tehran

Sponsors (1)

Lead Sponsor Collaborator
hahid Beheshti University of Medical Sciences

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Total and Surgical Induced Astigmatism At 1 and 4 weeks and 6 month after surgery